DE60113874D1 - Verfahren zur wiederherstellung des fettpolsters - Google Patents

Verfahren zur wiederherstellung des fettpolsters

Info

Publication number
DE60113874D1
DE60113874D1 DE60113874T DE60113874T DE60113874D1 DE 60113874 D1 DE60113874 D1 DE 60113874D1 DE 60113874 T DE60113874 T DE 60113874T DE 60113874 T DE60113874 T DE 60113874T DE 60113874 D1 DE60113874 D1 DE 60113874D1
Authority
DE
Germany
Prior art keywords
fat pad
recycling
host
fat
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60113874T
Other languages
English (en)
Other versions
DE60113874T2 (de
Inventor
Eric Andre Desrosiers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosyntech Canada Inc
Original Assignee
Biosyntech Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyntech Canada Inc filed Critical Biosyntech Canada Inc
Application granted granted Critical
Publication of DE60113874D1 publication Critical patent/DE60113874D1/de
Publication of DE60113874T2 publication Critical patent/DE60113874T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Prostheses (AREA)
  • Eye Examination Apparatus (AREA)
  • External Artificial Organs (AREA)
DE60113874T 2000-11-15 2001-11-14 Verfahren zur wiederherstellung des fettpolsters Expired - Lifetime DE60113874T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US55493 1987-05-28
US24822800P 2000-11-15 2000-11-15
US248228P 2000-11-15
US24857000P 2000-11-16 2000-11-16
US248570P 2000-11-16
US10/055,493 US6989373B2 (en) 2000-11-15 2001-10-29 Method for restoring a fat-pad
PCT/CA2001/001586 WO2002039977A2 (en) 2000-11-15 2001-11-14 A method for restoring a foot fat-pad

Publications (2)

Publication Number Publication Date
DE60113874D1 true DE60113874D1 (de) 2006-02-16
DE60113874T2 DE60113874T2 (de) 2006-07-13

Family

ID=27368850

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113874T Expired - Lifetime DE60113874T2 (de) 2000-11-15 2001-11-14 Verfahren zur wiederherstellung des fettpolsters

Country Status (9)

Country Link
US (1) US6989373B2 (de)
EP (1) EP1339393B1 (de)
JP (1) JP2004517655A (de)
AT (1) ATE305773T1 (de)
AU (1) AU2002218081A1 (de)
CA (1) CA2429009C (de)
DE (1) DE60113874T2 (de)
ES (1) ES2250515T3 (de)
WO (1) WO2002039977A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2569736A1 (en) * 2004-08-20 2006-03-02 Russell Anderson Methods of administering microparticles combined with autologous body components
EP2296637B1 (de) 2008-04-24 2014-04-02 Medtronic, Inc Chitosan enthaltende schutz-zusammensetzung
ES2610881T3 (es) 2008-04-24 2017-05-03 Medtronic, Inc Gel protector basado en quitosano y polisacárido oxidado
JP2011518837A (ja) 2008-04-24 2011-06-30 メドトロニック，インコーポレイテッド 再水和可能なチオール化多糖粒子およびスポンジ
US8653319B2 (en) 2008-04-24 2014-02-18 Medtronic, Inc. Cold ionizing radiation sterilization
US8230620B2 (en) * 2009-02-26 2012-07-31 Brian Ebel Foot pad for relieving pain
WO2016201230A1 (en) 2015-06-10 2016-12-15 Rhodia Operations Phosphonated polysaccharides and gels and process for making same
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
FR3044557B1 (fr) * 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
US20180339085A1 (en) * 2017-05-24 2018-11-29 In2Bones Usa, Llc System and methods for soft-tissue augmentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911926A (en) * 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
EP1229940B1 (de) * 1999-11-15 2014-05-14 Piramal Healthcare (Canada) Limited Temperaturgesteuerte und ph-abhängige selbstgelierende biopolymere wässrige lösung

Also Published As

Publication number Publication date
AU2002218081A1 (en) 2002-05-27
DE60113874T2 (de) 2006-07-13
WO2002039977A3 (en) 2002-10-31
CA2429009C (en) 2012-10-23
EP1339393B1 (de) 2005-10-05
ATE305773T1 (de) 2005-10-15
WO2002039977A2 (en) 2002-05-23
ES2250515T3 (es) 2006-04-16
US20020094959A1 (en) 2002-07-18
JP2004517655A (ja) 2004-06-17
EP1339393A2 (de) 2003-09-03
CA2429009A1 (en) 2002-05-23
US6989373B2 (en) 2006-01-24

Similar Documents

Publication Publication Date Title
DE60137430D1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DE60113874D1 (de) Verfahren zur wiederherstellung des fettpolsters
ATE425254T1 (de) Verfahren zur herstellung vitamin-k-abhängiger proteine
HUP0300299A2 (hu) Szabad aminosavakat tartalmazó kompozíció
DE60107889D1 (de) Verfahren zur Behandlung von Kautschukzusammensetzungen enthaltend Soja Fettsäure, Sonnenblumen Fettsäure und deren Mischungen
DE69833071D1 (de) Blattrahmen-IC-Karte und Verfahren zur Herstellung derselben
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
DE60125747D1 (de) Verfahren zur herstellung von 2-halobenzoesäuren
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
DE59508556D1 (de) Verfahren zur Extraktion von natürlichen Aromen aus fett- und ölhaltigen Naturstoffen
DE60107987D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
DE69724047D1 (de) Verfahren zur Entschwefelung und zur Entziehung von Kohlensäure
DE60126943D1 (de) Kaelteresistente fettzusammensetzung sowie verfahren zur herstellung derselben
ATE408840T1 (de) Verfahren zur identifizierung von agenzien zur behandlung von anfällen, neurologischen erkrankungen, endokrinopathien und hormonalen erkrankungen
DE69811676D1 (de) Verfahren zur verminderung des gehaltes an langkettigen gesättigten fettsäuren in fettsäurezusammensetzungen
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60019123D1 (de) Verfahren zur behandlung von petroleumsäuren
DE60127538D1 (de) Verfahren zur herstellung von methionin
DE50105185D1 (de) Verfahren zur Herstellung von Dithiazolyldisulfiden
DE50104555D1 (de) Verfahren zur herstellung von tert.-butylestern aliphatischer c1-c4-carbonsäuren
DE69912838D1 (de) Verfahren zur erhöhung der fettfestigkeit und zur verbesserung der fleischqualität bei tieren
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE50113374D1 (de) Verfahren zur agglomeration von feinteiligen polybutadienlatices
DE60126211D1 (de) Zementklinker, zementzusammensetzung, verfahren zur herstellung von zementklinker und verfahren zur behandlung von alkalihaltigen abfällen
ATE382347T1 (de) Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition